CARsgen Therapeutics logo

CARsgen Therapeutics

Making Cancer Curable

87 employees · est. 2014 · Shanghai, China

VS
Korecyte Bio logo

Korecyte Bio

We provide the tools to make cell therapy safer and more effective for treating solid tumours and beyond.

2 employees · est. 2023 · London, United Kingdom

CARsgen Therapeutics is the older company (2014 vs 2023); CARsgen Therapeutics is the larger of the two.

Side-by-Side Comparison

CARsgen Therapeutics Korecyte Bio
Founded
2014 older 2023
Headquarters
Shanghai, China London, United Kingdom
Employees
87 larger 2
Industry
Not tracked yet Biotechnology, Health and Wellness
Funding Stage
IPO Not tracked yet
Total Funding
$676.00M Not tracked yet
Funding Rounds
5 Not tracked yet
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Biopharmaceutical, CAR T-cell Therapy, Hematologic Malignancies, Solid Tumors, Cell Therapy Platform, Target Discovery, Antibody Development, Clinical Trials, Commercial-scale Manufacturing, Safety Profile Improvement, Efficacy Enhancement, Treatment Cost Reduction, Immunotherapy, Glioblastoma Multiforme, Hepatocellular Carcinoma Biotech Startup, Cell Therapy, Cancer Treatment, CAR-T Immunotherapy, Solid Tumors, Netherlands, United Kingdom, Next-Generation Therapy, International Biotech, CAR-NK Therapy, CAR-Tregs, Immunotherapies, Clinical Research, Healthcare Innovation, Cancer Immunotherapy
Website
carsgen.com korecyte.com
CARsgen Therapeutics logo

About CARsgen Therapeutics

CARsgen Therapeutics, founded in 2014, operates at the forefront of biotech innovation with a mission encapsulated by its slogan: "Making Cancer Curable." This biopharmaceutical company, headquartered in China, aims to transform cancer treatment through its pioneering CAR T-cell therapies targeting...

Korecyte Bio logo

About Korecyte Bio

Korecyte Bio, a London-based cell therapy startup founded in 2023, is dedicated to advancing the field of cell therapy. The company's mission is to enhance the safety and efficacy of cell therapy for treating solid tumors and beyond. With a focus on next-generation cell therapy tools, Korecyte Bio a...

We will tell you when either one moves

BounceWatch watches CARsgen Therapeutics and Korecyte Bio for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at CARsgen Therapeutics and Korecyte Bio — by email.

Frequently Asked Questions

CARsgen Therapeutics — Making Cancer Curable. Korecyte Bio — We provide the tools to make cell therapy safer and more effective for treating solid tumours and beyond.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
CARsgen Therapeutics has raised $676.00M while Korecyte Bio has raised undisclosed funding.
CARsgen Therapeutics and Korecyte Bio operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare CARsgen Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at CARsgen Therapeutics on 11 Mar 2026, and Korecyte Bio on 14 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes